Outcome of hospitalized MDR-TB patients: Israel 2000–2005

被引:0
作者
D. Bendayan
A. Hendler
V. Polansky
M. Weinberger
机构
[1] Shmuel Harofe Hospital,Pulmonary and Tuberculosis Department
[2] Tel Aviv University,Affiliated to the Sackler School of Medicine
[3] Assaf Harofe Hospital Medical Center,Infectious Diseases Unit
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2011年 / 30卷
关键词
Tuberculosis; Former Soviet Union; Sputum Smear; Direct Observe Therapy; Line Drug;
D O I
暂无
中图分类号
学科分类号
摘要
MDR-TB has emerged in Israel following an immigrations wave from the Former Soviet Union (FSU) and Ethiopia. The purpose of this study was to outline characteristics and outcome of hospitalized MDR-TB patients. We retrospectively summarized charts of MDR-TB patients hospitalized in the national referral tuberculosis centers from January 2000 to December 2005, and followed them for 2 years. One hundred thirty-two patients were identified with a median age of 40 years and male predominance (77%). The majority of the patients were immigrants from FSU (83%) and Ethiopia (7.6%). They were characterized by alcohol (25.8%) and IV drug abuse (23.5%), presented with advanced disease manifested by hypoalbuminemia (50.8%) and smear positivity (70.5%). Cure was achieved in 50.3% and 30.4% died. Factors independently associated with death were patients’ age (OR = 1.036 for each year, 95%CI 1.0–1.1, p = 0.014), hypoalbuminemia (OR = 2.95, 95%CI 1.1–7.6, p = 0.025), smear positivity at diagnosis (OR = 3.7, 95%CI 1.2–11.4, p = 0.023), alcohol abuse (OR = 4.8, 95%CI 1.7–13.7, p = 0.004) and XDR-TB resistance pattern (OR 8.3, 95%CI 1.5–44.6, p = 0.014). This study brings out the poor prognosis of a highly vulnerable immigration population. Efforts should be focused on earlier diagnosis and treatment in a well controlled hospital environment and to professional support groups to attend to this population’s special needs.
引用
收藏
页码:375 / 379
页数:4
相关论文
共 140 条
  • [1] Zignol M(2006)Global incidence of multidrug resistant tuberculosis J Infect Dis 194 479-485
  • [2] Hosseini MS(2006)Multidrug resistant tuberculosis: a menace that threatens to destabilize tuberculosis control Chest 130 261-272
  • [3] Wrigh A(2008)Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens AJRCCM 178 306-312
  • [4] Weezenbeck CL(1999)Drug resistant pulmonary tuberculosis in Israel, a society of immigrants: 1985–1994 Int J Tuberc Lung Dis 3 689-694
  • [5] Numn P(2003)The new national tuberculosis control programme in Israel, a country of high immigration Int J Tuberc Lung Dis 7 828-836
  • [6] Watt CJ(1994)A 10 year survey on Isr J Med Sci 30 805-810
  • [7] Sharma SK(1997) isolates in Israel and their drug resistance Isr J Med Sci 33 728-733
  • [8] Mohan A(2000)Emergence of drug-resistant tuberculosis in Jerusalem: ten-year retrospective review Chest 117 738-743
  • [9] Mak A(2004)Epidemiology and ethnic distribution of multidrug-resistant tuberculosis in southern Israel, 1992-1997: the impact of immigration Am J Respir Crit Care Med 169 1103-1109
  • [10] Thomas A(2005)Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis Lancet 365 318-326